What is the risk of relapse and active tumor after autologous transplant, with a 16 cm mass on MRI showing mild uptake on PET, following radiation therapy?
After autologous transplant for DLBCL, the situation you're describing requires careful interpretation. A 16 cm mass is considered bulky disease (typically defined as Show Full Answer
What is the risk of relapse and active tumor after autologous transplant, with a 16 cm mass on MRI showing mild uptake on PET, following radiation therapy?
After autologous transplant for DLBCL, the situation you're describing requires careful interpretation. A 16 cm mass is considered bulky disease (typically defined as larger than 10 cm, or sometimes 7.5 cm in DLBCL). The mild uptake on PET scan is an important finding that needs clinical correlation.
Understanding PET Uptake:
Mild uptake on PET after treatment can be challenging to interpret. It doesn't automatically mean active lymphoma - it could represent inflammation from treatment, scar tissue, or residual disease. Your oncologist will likely consider the intensity of uptake and compare it to baseline scans.
Relapse Risk Factors:
Several factors affect your relapse risk after transplant:
- The size of remaining disease (16 cm is significant)
- Your response to initial treatment before transplant
- How long you've been in remission
- Your IPI score and other prognostic factors
The risk of DLBCL relapse is highest within the first two years after completing treatment. If DLBCL returns within this window, it's called an early relapse. Late relapses (after two years) occur less frequently.
After Radiation Therapy:
Radiation therapy is sometimes used for bulky disease or to treat specific problem areas. Following radiation, your medical team will monitor you closely with imaging to assess response and watch for any signs of progression.
Next Steps:
Your oncologist may recommend:
- Follow-up imaging to track changes
- Possible biopsy if there's concern about active disease
- Continued monitoring schedule
- Discussion of additional treatment options if needed
It's important to have an open conversation with your healthcare team about what the imaging findings mean specifically for your situation and what the monitoring plan will be going forward.
April 20
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
